Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Rockwell Medical Inc.

Start price
Target price
Perf. (%)
€1.56
03.08.24
-
03.08.25
53.47%
17.08.24

KongVestor 
03.08.24 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€17.90
03.08.24
-
03.08.25
5.59%
17.08.24

KongVestor 
03.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€990.00
02.08.24
€1,099.6
02.08.25
-8.26%
22:26

JPMorgan Chase & Co. 
02.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€990.00
02.08.24
€1,136.2
02.08.25
-8.26%
22:26

Royal Bank of Canada 
02.08.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.28
02.08.24
€6.00
-
04.08.24

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
michaelkr 
02.08.24 70%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€188.45
02.08.24
€267.50
02.08.25
-11.30%
22:26

Royal Bank of Canada 
02.08.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€249.10
02.08.24
€274.83
02.08.25
-2.37%
22:26

Royal Bank of Canada 
02.08.24 50%
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.40
02.08.24
€50.39
02.08.25
-8.91%
03.10.24

Royal Bank of Canada 
02.08.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€453.20
02.08.24
€511.18
02.08.25
-9.75%
22:26

Guggenheim 
02.08.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€45.02
02.08.24
€64.13
02.08.25
-23.35%
22:26

Guggenheim 
02.08.24 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€140.30
02.08.24
€164.90
02.08.25
-27.12%
22:26

Guggenheim 
02.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€991.00
02.08.24
€1,190.9
02.08.25
-8.36%
22:26

Guggenheim 
02.08.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€46.20
02.08.24
€68.71
02.08.25
3.46%
04.10.24

Wells Fargo & Company 
02.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€992.60
02.08.24
€1,099.3
02.08.25
-8.50%
22:26

Wells Fargo & Company 
02.08.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€247.40
02.08.24
€251.93
02.08.25
-1.70%
22:26

Raymond James 
02.08.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€46.20
02.08.24
€69.62
02.08.25
3.46%
04.10.24

The Goldman Sachs Group, Inc. 
02.08.24 50%
sell
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€45.02
02.08.24
€33.91
02.08.25
-23.35%
22:26

The Goldman Sachs Group, Inc. 
02.08.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€247.40
02.08.24
€313.41
02.08.25
-1.70%
22:26

Citigroup Inc. 
02.08.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€10.98
02.08.24
€22.91
02.08.25
8.16%
22:26

B. Riley 
02.08.24 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€140.30
02.08.24
€200.69
02.08.25
-27.12%
22:26

Oppenheimer Holdings Inc. 
02.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€990.00
02.08.24
€1,116.5
02.08.25
-8.26%
22:26

Barclays PLC 
02.08.24 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€139.00
02.08.24
€164.74
02.08.25
-26.44%
22:26

Barclays PLC 
02.08.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€46.20
02.08.24
€106.16
02.08.25
3.46%
04.10.24

Cantor Fitzgerald 
02.08.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€452.65
02.08.24
€439.34
02.08.25
-9.64%
22:26

Cantor Fitzgerald 
02.08.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
02.08.24
€47.60
02.08.25
-
29.01.24

Robert W. Baird 
02.08.24 50%